Weigaojing announced that the company issued shares to purchase 100% of the shares of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. and related transactions were recently approved by the China Securities Regulatory Commission. The Securities Regulatory Commission approved the company's registration application to issue 255.8702 million shares to Shandong Weigao Group Medical Polymer Products Co., Ltd., 10,938,500 shares to Weihai Shengxi Enterprise Management Consulting Center, and 5.1893 million shares to Weihai Ruiming Enterprise Management Consulting Partnership to purchase related assets. The approval is valid for 12 months from the date of issuance. The company will handle matters related to this transaction within the specified period.

Weigaojing announced that the company issued shares to purchase 100% of the shares of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. and related transactions were recently approved by the China Securities Regulatory Commission. The Securities Regulatory Commission approved the company's registration application to issue 255.8702 million shares to Shandong Weigao Group Medical Polymer Products Co., Ltd., 10,938,500 shares to Weihai Shengxi Enterprise Management Consulting Center, and 5.1893 million shares to Weihai Ruiming Enterprise Management Consulting Partnership to purchase related assets. The approval is valid for 12 months from the date of issuance. The company will handle matters related to this transaction within the specified period.